Cargando…

Effect of external use of Qingluo San on clinical efficacy in patients with acute gouty arthritis

OBJECTIVE: The present study aimed to observe the clinical efficacy of the external use of Qingluo San combined with diclofenac sodium double-release enteric capsules in the treatment of acute gouty arthritis (dampness–heat accumulation syndrome). METHODS: A total of 58 acute gouty arthritis patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Chun, Yang, Fang, Zhu, Fubing, Hua, Dongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650848/
https://www.ncbi.nlm.nih.gov/pubmed/36369177
http://dx.doi.org/10.1186/s40001-022-00872-z
_version_ 1784828114414600192
author Shu, Chun
Yang, Fang
Zhu, Fubing
Hua, Dongping
author_facet Shu, Chun
Yang, Fang
Zhu, Fubing
Hua, Dongping
author_sort Shu, Chun
collection PubMed
description OBJECTIVE: The present study aimed to observe the clinical efficacy of the external use of Qingluo San combined with diclofenac sodium double-release enteric capsules in the treatment of acute gouty arthritis (dampness–heat accumulation syndrome). METHODS: A total of 58 acute gouty arthritis patients were divided into two groups using the random number table method. Diclofenac sodium double-release enteric capsules were orally administered in the control group. Based on the treatment in the control group, the external use of Qingluo San was given in the treatment group, with 7-day course of treatment. The changes in visual analog scale (VAS) scores, the tenderness, swelling, and mobility function of the joint, and the traditional Chinese medicine (TCM) syndrome scores before and after the treatment, at day 0, 1, 3, 5 and 7, were observed in both groups, together with the comparison of laboratory indicators (erythrocyte sedimentation rate, ESR; C-reactive protein, CRP; uric acid, UA). RESULTS: The total effective rate was 96.55% in the treatment group and 82.76% in the control group. After treatment, the VAS score, the tenderness, swelling and function scores of the joint, and the TCM syndrome scores decreased in both groups. The treatment group was superior in improving the VAS scores, the tenderness, swelling and mobility function of the joint, and TCM syndrome scores, when compared to the control group (p < 0.05). The laboratory indicators, which included the ESR, CRP and UA, obviously decreased in both groups after treatment (p < 0.05). The ESR significantly decreased in the treatment group, when compared to the control group (p < 0.05). CONCLUSION: The combination of the external use of Qingluo San and oral administration of diclofenac sodium double-release enteric capsules can more rapidly relieve joint pain, and improve the clinical efficacy. This combination therapy also has certain advantages in relieving joint swelling and improving the mobility function of the joint. Hence, this is worthy of clinical promotion and application.
format Online
Article
Text
id pubmed-9650848
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96508482022-11-15 Effect of external use of Qingluo San on clinical efficacy in patients with acute gouty arthritis Shu, Chun Yang, Fang Zhu, Fubing Hua, Dongping Eur J Med Res Research OBJECTIVE: The present study aimed to observe the clinical efficacy of the external use of Qingluo San combined with diclofenac sodium double-release enteric capsules in the treatment of acute gouty arthritis (dampness–heat accumulation syndrome). METHODS: A total of 58 acute gouty arthritis patients were divided into two groups using the random number table method. Diclofenac sodium double-release enteric capsules were orally administered in the control group. Based on the treatment in the control group, the external use of Qingluo San was given in the treatment group, with 7-day course of treatment. The changes in visual analog scale (VAS) scores, the tenderness, swelling, and mobility function of the joint, and the traditional Chinese medicine (TCM) syndrome scores before and after the treatment, at day 0, 1, 3, 5 and 7, were observed in both groups, together with the comparison of laboratory indicators (erythrocyte sedimentation rate, ESR; C-reactive protein, CRP; uric acid, UA). RESULTS: The total effective rate was 96.55% in the treatment group and 82.76% in the control group. After treatment, the VAS score, the tenderness, swelling and function scores of the joint, and the TCM syndrome scores decreased in both groups. The treatment group was superior in improving the VAS scores, the tenderness, swelling and mobility function of the joint, and TCM syndrome scores, when compared to the control group (p < 0.05). The laboratory indicators, which included the ESR, CRP and UA, obviously decreased in both groups after treatment (p < 0.05). The ESR significantly decreased in the treatment group, when compared to the control group (p < 0.05). CONCLUSION: The combination of the external use of Qingluo San and oral administration of diclofenac sodium double-release enteric capsules can more rapidly relieve joint pain, and improve the clinical efficacy. This combination therapy also has certain advantages in relieving joint swelling and improving the mobility function of the joint. Hence, this is worthy of clinical promotion and application. BioMed Central 2022-11-11 /pmc/articles/PMC9650848/ /pubmed/36369177 http://dx.doi.org/10.1186/s40001-022-00872-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shu, Chun
Yang, Fang
Zhu, Fubing
Hua, Dongping
Effect of external use of Qingluo San on clinical efficacy in patients with acute gouty arthritis
title Effect of external use of Qingluo San on clinical efficacy in patients with acute gouty arthritis
title_full Effect of external use of Qingluo San on clinical efficacy in patients with acute gouty arthritis
title_fullStr Effect of external use of Qingluo San on clinical efficacy in patients with acute gouty arthritis
title_full_unstemmed Effect of external use of Qingluo San on clinical efficacy in patients with acute gouty arthritis
title_short Effect of external use of Qingluo San on clinical efficacy in patients with acute gouty arthritis
title_sort effect of external use of qingluo san on clinical efficacy in patients with acute gouty arthritis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650848/
https://www.ncbi.nlm.nih.gov/pubmed/36369177
http://dx.doi.org/10.1186/s40001-022-00872-z
work_keys_str_mv AT shuchun effectofexternaluseofqingluosanonclinicalefficacyinpatientswithacutegoutyarthritis
AT yangfang effectofexternaluseofqingluosanonclinicalefficacyinpatientswithacutegoutyarthritis
AT zhufubing effectofexternaluseofqingluosanonclinicalefficacyinpatientswithacutegoutyarthritis
AT huadongping effectofexternaluseofqingluosanonclinicalefficacyinpatientswithacutegoutyarthritis